[New horizon of chronic myelogenous leukemia].
Tauchi
Tetsuzo
T
First Department of Internal Medicine, Tokyo Medical University.
Ohyashiki
Kazuma
K
D000970:Antineoplastic Agents / Q000627:therapeutic use*; D001555:Benzene Derivatives / Q000627:therapeutic use*; D000069439:Dasatinib; D006801:Humans; D015464:Leukemia, Myelogenous, Chronic, BCR-ABL Positive / Q000188:drug therapy*; D011743:Pyrimidines / Q000627:therapeutic use*; D013844:Thiazoles / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D001555:Benzene Derivatives; C499758:ON012380; D011743:Pyrimidines; D013844:Thiazoles; C498826:nilotinib; D000069439:Dasatinib